New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
08:35 EDTGILD, INFIGilead study 'alarming,' says Stifel
Stifel believes that a study of Gilead's (GILD) GS-9973+idelalisib - which it says terminated early due to the development of severe pneumonitis in nine patients - is "alarming." The firm adds that Gilead's results may prevent Infinity Pharmaceuticals (INFI) - which the firm thinks has plans to combine IPI-145 with a Btk inhibitor - from finding future commercial partners. However, it keeps Buy ratings on both Gilead and Infinity.
News For GILD;INFI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
13:01 EDTINFIInfinity Pharmaceuticals reports preclinical data for duvelisib with venetoclax
Subscribe for More Information
09:36 EDTGILDActive equity options trading on open
Subscribe for More Information
07:20 EDTGILDAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
April 15, 2015
16:01 EDTGILDOptions Update; April 15, 2015
iPath S&P 500 VIX Short-Term Futures down 49c to 21.90. Option volume leaders: AAPL NFLX C PBR KMI RIG MCP TWTR GILD BAC according to Track Data.
April 14, 2015
08:05 EDTINFIInfinity Pharmaceuticals names Sujay Kango as Chief Commercial Officer
Subscribe for More Information
April 13, 2015
16:01 EDTGILDOptions Update; April 13, 2015
Subscribe for More Information
09:34 EDTGILDActive equity options trading on open
Subscribe for More Information
April 10, 2015
16:05 EDTGILDOptions Update; April 10, 2015
Subscribe for More Information
April 9, 2015
06:12 EDTGILDSovaldi prices causes Medicaid spending for hepatitis C drugs to soar, WSJ says
Subscribe for More Information
April 7, 2015
17:58 EDTGILDGilead submits NDA for investigational combination for treatment of HIV-1
Subscribe for More Information
16:00 EDTGILDOptions Update; April 7, 2015
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use